OSSIO Inc., a medical technology company specializing in orthopedic implants, officially opened its new U.S. headquarters in Palmetto, Florida, on Wednesday. The celebration included Florida’s Lieutenant Governor, Jay Collins, and over 50 leaders from business, government, and healthcare, marking a significant milestone for the company that began operations in Israel in 2014.
The new facility spans 30,000 square feet and features a state-of-the-art product manufacturing plant alongside a comprehensive surgeon training center. OSSIO’s decision to expand its operations in Florida was driven by the state’s technical talent and favorable economic incentives, according to CEO Brian Verrier. He announced plans to create approximately 100 new jobs over the next five years, focusing on production, commercial, and administrative positions, with recruitment for these roles already underway since January.
During the ribbon-cutting ceremony, Lt. Gov. Collins emphasized Florida’s growing appeal as a hub for innovative healthcare companies. “OSSIO’s decision to establish its U.S. headquarters here in Palmetto reflects Florida’s strong workforce and commitment to supporting advanced manufacturing and medical innovation,” he stated. Collins highlighted that this investment would not only create high-quality jobs but also reinforce Florida’s position in the life sciences sector.
OSSIO’s innovative approach centers on its OSSIOfiber implants, which leverage Intelligent Bone Regeneration Technology. These implants are designed to provide a bio-integrative, metal-free fixation alternative, characterized by their mechanical strength and ability to promote natural healing. This advancement represents a significant leap in orthopedic fixation technology, addressing a broader range of surgical applications.
Verrier expressed enthusiasm about OSSIO’s future in Florida, stating, “We couldn’t feel more welcome in Florida. Our future in the Sunshine State is clearly bright.” He noted that the new headquarters would facilitate the company’s ambitious growth plans and enhance the local economy by attracting surgeons to the Gulf Coast for training on their innovative orthopedic technology.
Mark Glickman, President and CEO of BioFlorida, welcomed OSSIO as vital to the state’s medical technology landscape. “OSSIO represents exactly the kind of innovative, patient- and caregiver-focused company that continues to strengthen Florida’s position as a national powerhouse in medical technology,” he remarked. The establishment of OSSIO’s advanced manufacturing and training center underscores Florida’s robust life sciences ecosystem.
In comments from the Florida-Israel Business Accelerator (FIBA), co-executive director Rakefet Bachur-Phillips hailed OSSIO’s expansion as a landmark development for the Florida-Israel innovation corridor, appreciating the business’s commitment to improving patient outcomes through technology.
OSSIO’s implants, known as OSSIOfiber, are touted as the first credible alternative to traditional metal and absorbable fixation devices. With over 65,000 OSSIOfiber implants utilized in surgeries across the U.S. by the end of December 2025, the products are gaining traction among healthcare providers and patients alike, who often prefer to avoid the complications associated with metal implants.
Founded in 2014, OSSIO aims to transform the surgical experience across the orthopedic fixation market, with ongoing product development based in Caesarea, Israel, and commercial operations in Palmetto and Woburn, Massachusetts. The company’s vision remains focused on harnessing innovative technology to create life-changing medical solutions. For more information about OSSIO and its offerings, visit www.ossio.io.
The establishment of OSSIO’s headquarters in Florida signifies not only the company’s ambitions but also the growing importance of the state as a center for advanced medical technologies and innovations that promise to reshape the future of orthopedic care.
See also
Bank of America Warns of Wage Concerns Amid AI Spending Surge
OpenAI Restructures Amid Record Losses, Eyes 2030 Vision
Global Spending on AI Data Centers Surpasses Oil Investments in 2025
Rigetti CEO Signals Caution with $11 Million Stock Sale Amid Quantum Surge
Investors Must Adapt to New Multipolar World Dynamics
